Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

Clinical trial NCT05671991 · RECRUITING

Trial details

NCT number: NCT05671991
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

End Stage Renal Disease on Dialysis

Start date: 2023-03-01
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.